アレルギー性血管炎の英語

アレルギー性疾患（アレルギー性鼻炎、アレルギー性結膜炎、アトピー性皮膚炎、気管支喘息、食物アレルギー等）、全身性肥満細胞症、全身性肥満細胞活性化障害、アナフィラキシーショック、気道収縮、蕁麻疹、湿疹、痒みを伴う疾患、炎症、慢性閉塞性肺疾患、虚血再灌流障害、脳血管障害、慢性関節リウマチ、胸膜炎、潰瘍性大腸炎等の疾患の予防および／または治療に有用な化合物の提供。例文帳に追加

To provide compounds useful for prevention and/or treatment of diseases such as allergic diseases (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mast cell disease, systemic mast cell activation failure, anaphylactic shock, respiratory tract contraction, urticaria, eczema, diseases associated with itch, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion injury, cerebrovascular disorder, rheumatoid arthritis, pleuritis, ulcerative colitis. - 特許庁

パーキンソン病、認知障害、脳血管疾患、脳卒中、鬱血性心疾患、高血圧症、アレルギー性鼻炎、自己免疫および炎症疾患、または女性の性機能障害等に有効な新規化合物、およびその製造方法の提供。例文帳に追加

To provide a novel compound, as well as a method for manufacturing the same, effective to Parkinson's disease, cognitive impairment, cerebrovascular disease, stroke, congestive heart disease, hypertension, allergic rhinitis, autoimmune and inflammatory diseases, or female sexual dysfunction, etc. - 特許庁

動物の自己免疫疾患、アレルギー性疾患、癌あるいは炎症性疾患を治療する方法、創傷治癒を促進する方法、及び動物の器官あるいは組織における血管形成を促進する方法の提供。例文帳に追加

To provide a method of treating autoimmune diseases, allergic diseases, cancer, or inflammatory diseases in animals, a method of promoting would healing, and a method of promoting angiogenesis in an organ or tissue of an animal. - 特許庁

慢性リウマチ、アレルギー性鼻炎、喘息、心臓血管疾患などの医薬の中間体として有用性が期待される１−置換ピラゾール−４−カルボン酸を簡便に高収率で製造する方法を提供する。例文帳に追加

To provide a method for preparing a 1-substituted pyrazole-4-carboxylic acid simply and in a high yield which is expected to have its usefulness as an intermediate of drugs for chronic rheumatism, allergic rhinitis, asthma, cardinovascular diseases and the like. - 特許庁

疾患には、アレルギー性炎症、アテローム斑形成および不安定なプラークの破綻、動脈再狭窄、バイパス移植片閉塞、ゴーシェ病、糖尿病、慢性関節リウマチ、多発性硬化症、移植片拒絶、移植片血管病変および腎炎が含まれ、ＩＬ−１８活性抑制による炎症性疾患の治療薬を提供する。例文帳に追加

To provide a therapeutic agent for inflammatory disease using an IL-18 activity suppression wherein the disease includes allergic inflammation, formation of Atherosclerotic plaques and breakdown of an unstable plaques, artery restenosis, occlusion of by-pass grafting, familial splenic anemia, diabetes, chronic rheumatoid arthritis, multiple sclerosis, graft rejection, transplant vasculopathy and nephritis. - 特許庁

本発明のＰＤＥ阻害剤は、ＰＤＥが関与すると考えられる種々の疾患、例えば、慢性閉塞性肺疾患、喘息、慢性動脈閉塞症、心血管病、炎症性疾患、アレルギー性疾患、血栓症、脳障害、高脂血症、肥満の治療に有用である。例文帳に追加

The PDE inhibitor of the invention is useful for treatment of various diseases, in which the PDE is thought to take part, for instance, chronic obstructive lung disease, asthma, chronic artery obstruction disease, cardiovascular disease, inflammatory disease, allergic disease, thrombosis, brain lesion, hyperlipomia, and obesity. - 特許庁

本発明のＣＯＸ−２活性阻害剤は、ＣＯＸ−１活性を実質的に阻害しないので、ＣＯＸ−１活性の阻害による副作用が生じる可能性が低く、炎症性疾患、アレルギー性疾患、血栓症、脳障害、癌、生活習慣病、心血管病などの種々の疾患の治療に非常に有用である。例文帳に追加

Since the COX-2 activity inhibitor does substantially not inhibit COX-1 activity, possibility for producing side effects by the inhibition of the COX-1 activity is low, and the COX-2 activity inhibitor is highly useful for treating various diseases such as inflammatory diseases, allergic diseases, thrombosis, cerebral disorders, cancers, life style-related diseases, and cardiovascular diseases. - 特許庁